Author:
Wu Dan, ,Zhang Yanyang,Tang Lin,Wang Fuzhen,Ye Ying,Ma Chao,Zheng Hui,Yu Wenzhou,Cao Lei,Song Yifan,Reyimu Abuduwaili,Zhang Xiaoxiao,Wang Haifeng,Nie Yifei,Lu Mingxia,Qi Muge,Li Jun,Wang Ruolin,Yang Kaichao,Wang Changshuang,Everett Rodewald Lawrence,Fu Gao Geroge,An Zhijie,Yin Zundong, , ,
Publisher
Chinese Center for Disease Control and Prevention
Subject
Applied Mathematics,General Mathematics
Reference9 articles.
1. COVID-19 Vaccine Technical Working Group. Technical vaccination recommendations for COVID-19 vaccines in China (First Edition). China CDC Wkly 2021;3(21):459 − 61. http://dx.doi.org/10.46234/ccdcw2021.083.
2. Liu FF, Zheng CJ, Wang LP, Geng MJ, Chen H, Zhou S, et al. Interpretation of the protocol for prevention and control of COVID-19 in China (Edition 8). China CDC Wkly 2021;3(25):527 − 30. http://dx.doi.org/10.46234/ccdcw2021.138.
3. National Health Commission of China. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 8). http://www.gov.cn/zhengce/zhengceku/2021-04/15/content_5599795.htm. [2022-1-10]. (In Chinese).
4. Al Kaabi N, Zhang Y, Xia S, Yang YK, Al Qahtani MM, Abdulrazzaq N, et al. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. JAMA 2021;326(1):35 − 45. http://dx.doi.org/10.1001/jama.2021.8565.
5. Palacios R, Batista AP, Albuquerque CSN, Patiño EG, Santos JDP, Conde MTRP, et al. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3822780. [2021-4-11].